241710 — Cosmecca Korea Co Income Statement
0.000.00%
- KR₩461bn
- KR₩609bn
- KR₩524bn
- 81
- 45
- 36
- 56
Annual income statement for Cosmecca Korea Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 339,056 | 396,466 | 399,399 | 470,719 | 524,329 |
Cost of Revenue | |||||
Gross Profit | 60,782 | 72,740 | 65,084 | 107,122 | 124,506 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 329,139 | 378,445 | 389,255 | 421,739 | 464,233 |
Operating Profit | 9,917 | 18,021 | 10,144 | 48,980 | 60,096 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 4,336 | 17,514 | 6,373 | 46,102 | 67,594 |
Provision for Income Taxes | |||||
Net Income After Taxes | 3,416 | 16,967 | 6,003 | 33,887 | 53,688 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 2,622 | 8,904 | 2,656 | 22,319 | 42,800 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2,622 | 8,904 | 2,656 | 22,319 | 42,800 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 335 | 1,174 | 322 | 2,079 | 4,027 |
Dividends per Share |